Karl Hess Email & Phone Number

United States

Boston , Ma, Us

Managing Director for HealthTech and digital health. Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering and corporate finance. The firm leverages its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and corporate markets and implementing the best path for success.The firm’s strength stems from its multi-disciplinary, industry experts who draw from their broad relationships and a wide range of scientific, operational, strategic and transactional expertise across the value chain. Comprised of former CEOs, business development executives, venture capitalists, PhD/MD-level scientists and clinicians, and experienced commercialization experts, our team is driven to propel innovation from bench to bedside.Outcome Capital is proud of its unique culture of intellectual agility and openness, data-driven perspectives, strategic thinking, and commitment to teamwork. We are devoted to providing unmatched advisory services to our clients and share an uncompromised dedication to the life sciences and healthcare industry success.

Hellerup, Gentofte, Dk

Novo Holdings is recognized as a leading international life science investor, with a focus on creating long-term value. As a life science investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets. Further information: www.novoholdings.dk.

Dallas, Tx, Us

OnDigitalHealth's proven digital health approach: Engagement = Expertise x Technology; Outcomes = Engagement x Strategy; abs(ROI) = Outcomes x ValueOnDigitalHealth is a digital health consulting firm providing expertise and consulting across the entire product lifecycle and continuum of digital health solutions, including:- Benchmarking, market research, VoC and stakeholder journey mapping- Strategy, growth & innovation - organic, inorganic & open- Business model / business plan development & refinement- Transactions: Securing funding, navigating strategic investments, private equity & M&A- Partnerships: Strategic partnerships & alliances, alliance & channel management- Business development: Successfully selling to big pharma, payers, providers & employers- Product development: UI/UX, technology platforms & core team-based (Agile) development processes- Creating & driving value: Developing your value proposition, creating & measuring ROI- Consumer engagement & retention strategies & tactics- Successful remote monitoring, telehealth & population health strategies- Digital transformations and change management

Texas Health Aetna is a joint venture of Texas Health Resources and Aetna, combining Texas Health's high-quality, local providers, and delivery systems with Aetna's health plan and care management expertise, analytical insights, and health information technology. Texas Health Aetna combines the strengths of traditional health care plans and health systems to create a truly integrated solution that's simple to navigate and puts the member's experience first. The local health plan is committed to providing access to affordable, high-quality health care services and delivering customized member experiences throughout the Dallas-Fort Worth metroplex. For more information, go to texashealthaetna.com.

Kalico Partners is a frail and vulnerable-focused, technology-enabled, licensed provider and population health management organization. Kalico provides a full spectrum of LT-PAC-focused offerings for its clients and partners, from access to a full suite of state-of-the-art digital and population health, HIT and interoperability technology platforms (which includes our own, internally-developed and proprietary technologies and platforms), to consulting and advisory services on population health management best practices and LT-PAC investment opportunities, to interim operational and clinical executive management. Our mission is to up level and “future proof” the long-term, post-acute care (LT-PAC) industry by bringing unparalleled expertise, proven technology and robust capabilities to bear in fulfillment of the Quadruple Aim and our clients’ and partners’ objectives to take on and successfully manage risk.

Pflugerville, Texas, Us

As CDHO at Collain Healthcare, I'm responsible for the oversight and direction of the design, implementation and support of best-practice digital and population health management programs as well as all related processes, expertise, technologies and partnerships, with a particular emphasis on frail and vulnerable populations (i.e., Medicare and Medicaid). My chief aim is to design and implement tailored, industry-leading digital health solutions and higher-level ecosystems which augment and further our clients' population health management objectives and capabilities, all the while providing for the highest of quality, sustainable competitive advantage and the maximization of incremental revenue streams. In short, we are helping our clients to enable actual population health management best practices and prepare for the future of value based care, now.

Seoul, Seoul, Kr

As Chief Commercial Officer for Collain Healthcare, an LG CNS Company, I was responsible for all clinical, market research, product development / management, branding, marketing, sales, customer success and strategic partnership efforts / execution across a broad portfolio of innovative digital health and population health management solutions. Led development of a fully-featured and best-in-class care / population health management platform (PaaS) within six months, including: - Forming regional, clinically-integrated networks, with all relevant stakeholders - Analytics: Retrospective, Definitive, Predictive, on cost, quality, GIC ID, etc. - Part B FFS: e.g., HRAs, AWVs, care plan development and oversight, ACP, CCM+, TCM, MNT, DSMT, leveraging telemedicine whenever possible / applicable, etc. - Care management, care coordination, care navigation, transitions of care, referral management - Remote patient monitoring (flexible enough to cover 100’s of different devices) - Digital health programs and services (chronic condition focused and others) - Robust library of patient-facing educational and self-management content - Providing for comprehensive 360-degree longitudinal patient records – which are actionable and holistic Developed numerous strategic partnerships across the digital and population health markets – creating an ecosystem and marketplace of solutions focused on supporting frail and vulnerable populations – for payer and provider organizations Closed numerous healthcare SaaS / PaaS contracts providing PHM, interoperability & analytics services

Denver, Co, Us

I was charged with identifying, exploring, cultivating, developing and managing external partnerships across 73 sub-categories of the digital health space for Welltok's CaféWell Connect Partner Program, commercializing such partnerships for Welltok's payer, provider and employer customer segments.Welltok enables population health managers to guide and incentivize consumers to optimize their health. Welltok's CaféWell Health Optimization Platform organizes the growing spectrum of health and condition management programs and resources, such as tracking devices, apps, and communities, and creates personalized, adaptive plans for each consumer based on their health status, benefits and goals. The platform leverages social, gaming and cognitive technologies to drive engagement, and helps sponsors increase revenue, improve operational efficiency and drive healthcare value.

LG CNS delivers state-of-the-art Smart Technology with patient-centered digital health solutions for the global healthcare industry and in alignment with the Triple Aim. LG CNS' Healthcare Solutions portfolio of products includes mHealth, telemedicine, certified Electronic Health Record (EHR), point-of-care, long-term care, population health management, big data and predictive analytics, implementation, integration and interoperability solutions and services. Patients are empowered by being able to access their Personal Health Record (PHR) data on a real-time basis, and they are engaged by being able to take a more proactive role in managing their own health, in close collaboration with their health care providers. Providers benefit from the platform’s mobility, accuracy, connectivity, robust data availability, real-time documentation and staff communication at the point-of-care and even remotely. Both patients and providers benefit from innovative, timely care delivery, truly coordinated care and expanded care access across home-based and clinical settings. Payer organizations can experience an unprecedented view of and access to a complete and real-time set of population and/or individual patient data, as well as unique insights into risk stratification, potential fraud, waste and abuse. LG CNS has developed comprehensive end-to-end solutions from the ground up that deliver cutting-edge capabilities to the healthcare industry to make our customers and clients Healthcare Ecosystem Leaders. Collain Healthcare is a subsidiary of LG CNS incorporated in 2014 with its principal office in Georgetown, Texas. Collain commercializes the solutions across North America powering sales, marketing, regulatory and operations teams for the LG CNS Healthcare Solutions portfolio.

Columbia, Maryland, Us

WellDoc is a healthcare technology company developing the next generation of solutions to transform the management of chronic disease. Our mission is to improve health outcomes and reduce healthcare costs by promoting positive behavior change and optimizing clinical decisions. Powered by a proprietary Automated Expert Analytics System, WellDoc solutions are often FDA cleared and deployed over the Internet, cell phones, and mobile medical devices to enable real-time patient and provider engagement.

A Leading Healthcare Investment Bank.Leerink Partners is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare.Leerink is a clear market leader in partnering with innovative healthcare companies to raise capital and position them for success in the public markets. Since 2009 we have bookrun over 80 public equity transactions for greater than $6 billion in proceeds; raising capital vital to the research and commercialization efforts of our corporate clients while simultaneously delivering strong returns for our investor clients.Leerink’s success in M&A is rooted in our long-term relationships. We recognize the true core asset of our firm is our clients’ trust. Leerink has announced and closed over 40 M&A transactions since July 2009 across sectors and structures. Leerink’s M&A advisory practice leverages the same proprietary insights and industry relationships that drive our leading capital markets franchise. Leerink’s senior advisory team guides our clients through acquisitions, sales, divestitures, and other corporate restructurings. Our industry expertise also makes us uniquely suited as an advisor in special committee situations.

A strategy consulting firm focused on improving the performance of technology and healthcare start-up companies.Managing Director, Owner, Founder responsible for all business development efforts, project / engagement planning, execution and delivery. Developed an extremely successful and saleable niche offering across defining/revising/revitalizing/optimizing strategy, business plans, prospectuses, funding pitches, capital raise messaging and presentation content, road show efforts, product portfolio, branding, marketing focus and creating marketing and social media platforms, with robust, companion analytic and reporting tools. Some of my chief accomplishments at BIU, LLC include:Solely sold and successfully delivered on $250K in projects at 12 different technology start-up companies.Developed ‘do more with less’ framework for optimizing start-up marketing, branding and social media efforts.Drove project results leading to $3.65MM in direct angel and venture capital investments in client companies.

Primary project work in strategy/strategic planning, innovation, product development, product lifecycle management, portfolio management, M&A, private equity, market, firm and product valuations, operational and business due diligence, licensing, alliance management, primary/secondary market research and competitive intelligence. Representative Deal Experience:$2.4B acquisition of a medical and dental imaging systems and healthcare IT solutions provider by a private equity client with $10B AUM (buy-side). Conducted business and operational due diligence and post-acquisition transformative performance initiative resulting in $125MM in EBITDA improvements.$540MM acquisition of transfusion medicine products manufacturer by a private equity consortium with $60B AUM (buy-side). Conducted sign-to-close and post-deal operational due diligence and post-acquisition transformative performance initiative resulting in over $75MM in realized EBITDA improvements.

Led client engagements and project planning at multiple client sites (concurrently) for numerous start-up, Fortune 1000 and government clients.Conducted in-depth primary market research with hundreds of KOLs / TLs within the cardiology, cardiovascular, neurology, oncology, and orthopedics (spine) specialties to assess market attractiveness, evaluate new product concepts, delineate segmentation and positioning, establish pricing, and determine customer satisfaction for dozens of new products and product concepts.Wrote numerous market research and intelligence reports, covering country-specific and global opportunities within several segments of the medical device market.

Proactive Medical Technologies, Inc., based in Austin, Texas, is a private, start-up company focused on the rapid development and commercialization of novel molecular analysis technologies that are strategically positioned to address the growing demand for efficient, cost effective clinical diagnostic testing. Led business and marketing plan development efforts in an effort to secure venture capital funding.

South San Francisco, California, Us

Co-led commercial assessments and developed in-licensing recommendations for 2 pre-clinical oncology biologics.Developed and launched an HTLM-based reference database for all historic FDA oncology approvals, period 1949-2004.Performed “Fast-to-Market” oncology market and pipeline opportunity analysis and ranked 15 oncology indications aligned with Genentech's R&D efforts and in-licensing strategy.Conducted case history study of several competitors’ approved oncology products’ development processes and timelines, for “lessons learned” analysis, with Regulatory Research.Determined, as part of the Drug Development Performance Initiative Team, best practices for the FDA oncology regulatory process and FDA / sponsor interactions.

Franklin Lakes, New Jersey, Us

Led global strategic and tactical management and business development efforts (with direct P&L responsibilities) for a life sciences product portfolio of $35M, to a CAGR of 22%.Launched dozens of new products with an incremental revenue total of $4.5M.Drove profit margin increase of more than 10% (from 57% to 63%) across the entire portfolio over a 3-year period.Initiated a standard costing review that resulted in a $750K COGS savings, FY02.Developed and implemented comprehensive marketing plans and worldwide market development and product positioning strategies, including unique value propositions, product branding, messaging and pricing for hundreds of existing and dozens of new products.Developed and managed a KOL panel of dozens of industry and key account R&D leaders.Evaluated and executed strategic licensing, OEM, M&A, co-marketing and alliance opportunities (over 30 opportunities evaluated between 2002-2003, with deal values up to $800M USD), including a $2.1M deal with an ROI of 69.5% (projected over 3 years).Served as Marketing Team Lead for design and implementation of a stage-gate product development process which resulted in an average 6-8 weeks/product faster time-to-market. Conducted primary market research (VoC, ethnographic methods) and deployed numerous competitive intelligence programs.Designed and launched BD Biosciences e-Marketing program, including the e-Catalog on-line pricing and ordering implementation, the WebEx initiative, and the Yesmail direct e-mail campaign.SAP R/3 Enterprise, CRM and PLM module Planning and Implementation Marketing Team Lead.

Waltham, Ma, Us

Ambion, Inc. is a market leader in the field of RNA-based life science research and molecular diagnostic products. Ambion maintains this leadership role by consistently developing innovative products for handling, preserving, isolating, detecting and measuring RNA. These products are used for research in areas such as molecular biology, cell biology, microbiology, drug discovery, genomics and molecular diagnostics.• Managed a $1.25M sales territory to over 50% growth in 1999 (to 113% of plan)• Conducted focus group, market research, forecasting and sales tracking activities• Developed and maintained direct-mail, e-marketing and CRM databases in Access

Dallas, Texas, Us

UT Southwestern is an academic medical center, world-renowned for its research, widely respected for its teaching and training, and highly regarded for the quality of clinical care its faculty provides to patients at UT Southwestern University Hospitals & Clinics and its affiliated hospitals. Some of my responsibilities and accomplishments included:• Managed $1M annual laboratory budget, all lab personnel (5) and databases • Research activities focused on brain and reproductive system cancers and other pathologies, and entailed working with RNA, DNA and protein, in numerous assay formats• Novel gene discovery and cloning (“MORC”, U.S. Patent 6,632,934)

Waltham, Ma, Us

• Mapped out and managed production schedules and development projects for dozens of products• Planned, executed and followed-up on internal and external departmental process audits• Conducted efficiency identification and business process improvement analysis and implementation

B.A., Molecular Biology

Mba, Management And Finance